Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cholesterol-lowering chocolate?

This article was originally published in The Tan Sheet

Executive Summary

Randomized, double-blind, placebo-controlled trial finds dietary chocolate enriched with 1.8 g/day tall oil-derived phytosterols "is effective in lowering blood total and LDL cholesterol levels in subjects with mild hypercholesterolemia" and may help reduce risk of coronary heart disease in these individuals. Published in British Journal of Nutrition, study found LDL cholesterol levels were statistically significantly reduced by 10.3%, total cholesterol by 6.4% with phytosterol-enriched chocolate, while cholesterol levels did not change in placebo group. Jacqueline de Graaf, University Medical Centre Nijmegen, The Netherlands, et al., randomized 70 participants ages 21-75 to receive either three chocolate servings/day containing tall oil-phytosterol mixture or placebo chocolate for four weeks. No adverse events were reported. Vancouver-based Forbes Medi-Tech provided fortified chocolates for the study...

You may also be interested in...



Faster, Better? Fujitsu, Polarisqb 'Quantum-Inspired' Tech Speeds Discovery

Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.

Keeping Track: Oncology Submissions From Blueprint, Y-mAbs, BMS/bluebird; Approvals For BMS’ Reblozyl, LFB’s SevenFact

The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.

Part B Drugs At Home: Medicare Policy Responds To COVID-Driven Access Concerns

Temporary policy may open door to longer term change as Medicare allows reimbursement of at-home administration of non-hospital drugs covered by Part B under a recently-released regulation aiding at encouraging telehealth during the coronavirus outbreak.

Topics

UsernamePublicRestriction

Register

PS094894

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel